MediXall (MDXL) Enterprise Value (2019 - 2024)
MediXall's Enterprise Value history spans 8 years, with the latest figure at -$31916.0 for Q3 2024.
- For Q3 2024, Enterprise Value fell 230.15% year-over-year to -$31916.0; the TTM value through Sep 2024 reached -$31916.0, down 230.15%, while the annual FY2023 figure was -$10721.0, 213.85% down from the prior year.
- Enterprise Value reached -$31916.0 in Q3 2024 per MDXL's latest filing, up from -$32621.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$2289.0 in Q1 2023 to a low of -$1.3 million in Q1 2021.
- Average Enterprise Value over 5 years is -$224293.1, with a median of -$75578.0 recorded in 2022.
- Peak YoY movement for Enterprise Value: skyrocketed 97.8% in 2023, then crashed 2250.94% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$645762.0 in 2020, then surged by 90.18% to -$63418.0 in 2021, then surged by 94.61% to -$3416.0 in 2022, then tumbled by 213.85% to -$10721.0 in 2023, then tumbled by 197.7% to -$31916.0 in 2024.
- Per Business Quant, the three most recent readings for MDXL's Enterprise Value are -$31916.0 (Q3 2024), -$32621.0 (Q2 2024), and -$53813.0 (Q1 2024).